Keun-Hwa Jung Selected Research

Epilepsy (Aura)

1/2022	Neuropsychiatric symptoms and seizure related with serum cytokine in epilepsy patients.
11/2021	Proteins related to ictogenesis and seizure clustering in chronic epilepsy.
1/2021	A new rapid titration protocol for lamotrigine that reduces the risk of skin rash.
12/2020	HLAs associated with perampanel-induced psychiatric adverse effects in a Korean population.
1/2020	Usefulness of saliva for perampanel therapeutic drug monitoring.
1/2019	Impact of a selective cyclooxygenase-2 inhibitor, celecoxib, on cortical excitability and electrophysiological properties of the brain in healthy volunteers: A randomized, double-blind, placebo-controlled study.
1/2018	HLA-A*11:01 is associated with levetiracetam-induced psychiatric adverse events.
1/2018	Clustering of spontaneous recurrent seizures separated by long seizure-free periods: An extended video-EEG monitoring study of a pilocarpine mouse model.
1/2018	Possible epigenetic regulatory effect of dysregulated circular RNAs in epilepsy.
3/2017	Three-Year Retention Rates of Levetiracetam, Topiramate, and Oxcarbazepine: A Retrospective Hospital-Based Study.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Keun-Hwa Jung Research Topics

Disease

31	Stroke (Strokes) 01/2022 - 06/2004
23	Epilepsy (Aura) 01/2022 - 08/2006
20	Cerebral Hemorrhage 10/2019 - 09/2003
15	Inflammation (Inflammations) 05/2018 - 08/2004
14	Ischemic Stroke 01/2022 - 07/2004
13	Ischemia 02/2016 - 08/2004
12	Seizures (Absence Seizure) 01/2022 - 06/2004
12	Encephalitis (Encephalitis, Rasmussen) 10/2018 - 12/2007
10	Brain Ischemia (Cerebral Ischemia) 06/2013 - 09/2003
9	Brain Edema (Cerebral Edema) 02/2016 - 08/2004
9	Hematoma 01/2014 - 07/2004
8	Status Epilepticus (Complex Partial Status Epilepticus) 12/2015 - 06/2004
6	Autoimmune Diseases of the Nervous System 01/2018 - 01/2016
6	Atrophy 01/2017 - 07/2004
6	Brain Diseases (Brain Disorder) 04/2016 - 12/2012
6	Nervous System Diseases (Neurological Disorders) 01/2016 - 03/2007
5	Atrial Fibrillation 01/2022 - 05/2015
5	Alzheimer Disease (Alzheimer's Disease) 01/2019 - 01/2012
5	Glioma (Gliomas) 10/2018 - 12/2013
5	Infarction (Infarctions) 03/2017 - 10/2005
5	Anti-N-Methyl-D-Aspartate Receptor Encephalitis 02/2017 - 04/2014
4	Huntington Disease (Huntington's Disease) 01/2017 - 11/2006
4	Hemorrhage 01/2017 - 04/2006
4	Neoplasms (Cancer) 01/2016 - 03/2011
3	Transient Ischemic Attack 01/2022 - 05/2015
3	Exanthema (Rash) 01/2021 - 10/2018
3	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021 - 01/2017
3	Disease Progression 01/2019 - 03/2007
3	Intracranial Aneurysm (Cerebral Aneurysm) 01/2018 - 12/2012
3	Drug-Related Side Effects and Adverse Reactions 01/2017 - 10/2015
3	Limbic Encephalitis (Paraneoplastic Limbic Encephalitis) 01/2016 - 12/2013
3	Edema (Dropsy) 01/2014 - 01/2004
2	Meningitis 01/2021 - 11/2017
2	Bacterial Meningitis 01/2021 - 09/2019
2	Orthostatic Hypotension (Postural Hypotension) 01/2020 - 09/2017
2	Postural Orthostatic Tachycardia Syndrome 05/2019 - 01/2018
2	Hypoxia (Hypoxemia) 03/2019 - 05/2008
2	Pneumonia (Pneumonitis) 01/2019 - 10/2018
2	Cognitive Dysfunction 10/2018 - 02/2016
2	Hyponatremia 10/2018 - 03/2014
2	Orthostatic Intolerance 09/2018 - 01/2018
2	Generalized Epilepsy 01/2018 - 01/2017
2	Hypertension (High Blood Pressure) 03/2017 - 01/2011

Drug/Important Bio-Agent (IBA)

11	Pilocarpine (Ocusert)FDA LinkGeneric 11/2021 - 06/2004
10	Anticonvulsants (Antiepileptic Drugs)IBA 01/2021 - 02/2010
8	Proteins (Proteins, Gene)FDA Link 11/2021 - 10/2005
8	MicroRNAs (MicroRNA)IBA 01/2018 - 01/2011
7	N-Methyl-D-Aspartate Receptors (NMDA Receptors)IBA 02/2017 - 04/2006
6	Levetiracetam (Keppra)FDA LinkGeneric 10/2018 - 09/2013
6	AntibodiesIBA 01/2018 - 04/2014
6	Neuroprotective AgentsIBA 06/2013 - 07/2004
5	Glucose (Dextrose)FDA LinkGeneric 10/2021 - 02/2006
5	Leucine (L-Leucine)FDA Link 10/2018 - 12/2013
4	CytokinesIBA 01/2022 - 03/2006
4	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 01/2019 - 08/2004
4	Celecoxib (Celebrex)FDA Link 01/2019 - 08/2004
4	Oxcarbazepine (Trileptal)FDA LinkGeneric 10/2018 - 03/2014
4	AnticoagulantsIBA 01/2018 - 06/2004
4	Erythropoietin FDA Link 01/2012 - 03/2006
4	NitritesIBA 08/2011 - 11/2006
4	Memantine (Namenda)FDA Link 01/2009 - 04/2006
4	Peroxidase (Myeloperoxidase)IBA 12/2007 - 08/2004
3	Interleukin-2 (IL2)IBA 01/2022 - 01/2016
3	Interleukin-6 (Interleukin 6)IBA 01/2022 - 03/2008
3	Biomarkers (Surrogate Marker)IBA 01/2021 - 02/2016
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 01/2019
3	Oxygen (Dioxygen)IBA 01/2021 - 02/2006
3	Lamotrigine (Lamictal)FDA LinkGeneric 01/2021 - 10/2015
3	Pharmaceutical PreparationsIBA 01/2020 - 01/2018
3	Long Noncoding RNAIBA 10/2019 - 07/2015
3	Hemoglobins (Hemoglobin)IBA 01/2019 - 01/2011
3	Therapeutic UsesIBA 01/2017 - 03/2007
3	Rituximab (Mabthera)FDA Link 10/2016 - 01/2016
3	Valproic Acid (Depakote)FDA LinkGeneric 01/2014 - 05/2007
3	Collagenases (Collagenase)FDA Link 01/2010 - 08/2004
3	LithiumIBA 03/2009 - 10/2004
3	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 02/2006 - 04/2005
2	Amyloid (Amyloid Fibrils)IBA 01/2022 - 01/2012
2	Antiphospholipid AntibodiesIBA 01/2022 - 01/2022
2	phenyl-2-aminoethyl sulfide (PAES)IBA 12/2020 - 01/2018
2	HLA Antigens (Human Leukocyte Antigens)IBA 12/2020 - 05/2019
2	Midodrine (Midon)FDA LinkGeneric 01/2020 - 09/2017
2	Messenger RNA (mRNA)IBA 10/2019 - 01/2018
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 03/2019 - 09/2011
2	Circular RNAIBA 01/2019 - 01/2018
2	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 11/2018 - 07/2004
2	16S Ribosomal RNAIBA 10/2018 - 11/2017
2	hydroxide ionIBA 09/2018 - 09/2017
2	CalciumIBA 05/2018 - 04/2006
2	Pyridostigmine Bromide (Pyridostigmine)FDA LinkGeneric 01/2018 - 09/2017
2	Indicators and Reagents (Reagents)IBA 01/2018 - 03/2017
2	Topiramate (Topamax)FDA LinkGeneric 03/2017 - 01/2013
2	AutoantibodiesIBA 02/2017 - 12/2013
2	CytosineIBA 01/2017 - 06/2004

Therapy/Procedure

32	Therapeutics 01/2022 - 09/2008
12	Transplantation 01/2017 - 09/2003
10	Immunotherapy 01/2018 - 12/2013
2	Thrombectomy 12/2020 - 08/2018
2	Stents 07/2018 - 12/2012
2	Aftercare (After-Treatment) 01/2018 - 09/2011